Skip to main content
Caplight Logo









Kinomica

Kinomica

Private
MacclesfieldHealthcare & Life Scienceshttps://kinomica.com/

Last Round

VC Round

Jul 24, 2024

Total Funding Raised

$9.44M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Kinomica is a biotechnology company that has developed a phosphoproteomic diagnostic platform designed to enhance tailored treatment decisions involving anticancer drug therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

phosphoproteomicscell signaling analysiskinase activityprecision medicinemass spectrometrybiomarker identificationdrug discoverybioinformaticspredictive oncologyproteomicsliquid chromatography-mass spectrometryLC-MSmulti-omicstranslational medicinebiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kinomica Comparables

Compare Kinomica with similar companies based on industry and business-model similarity.

Kinomica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Panome Bio
79%
Bruker
74%
Proteome Sciences plc
73%

Kinomica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 24, 2024
GrantJan 1, 2023
GrantMar 1, 2022
Series ADec 14, 2020
SeedJul 1, 2019
Grant
Jun 1, 2019

Key People

Founding team and executive leadership

Tim Fell

Chief Executive Officer

Executive Team

Arran Dokal

Chief Technology Officer

Executive Team

Kinomica Investors

Notable investors and investment history

Kinomica investors
InvestorRounds
Innovate UKGrant
BGFVC Round, Series A
Pioneer GroupSeries A, Seed
Mercia VenturesVC Round
Puffin PointSeries A
Longwall Venture PartnersVC Round, Series A
Innovate UKSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 1367% MoM, from 18 to 264.

  • Jul 24, 2024

    $1.78M round led by Mercia Ventures

Kinomica Filings

Explore SEC and related filing metadata, where available.

Kinomica filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kinomica's valuation, stock price, and market status.

Is Kinomica a public or private company?

Kinomica is a private company.

What is the current stock price of Kinomica?

Kinomica is a private company with no public stock price. No recent secondary market data is available.

How much is Kinomica worth (valuation)?

Valuation information for Kinomica is not publicly available.

Can I buy Kinomica stock?

Kinomica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kinomica's last funding round?

Kinomica's most recent funding round was VC Round on July 24, 2024.

Who are the main investors in Kinomica?

Key investors in Kinomica include BGF, Pioneer Group, Mercia Ventures.

Will Kinomica IPO soon?

No public IPO plans have been announced for Kinomica.

How can I track Kinomica secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kinomica's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMacclesfield
Employee Range24
Year Founded2016
Last FundingJul 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?